Clinical aspects of cell death in breast cancer: The polyamine pathway as a new target for treatment

N. E. Davidson, H. A. Hahm, D. E. McCloskey, P. M. Woster, Robert A Casero

Research output: Contribution to journalArticle

Abstract

Because intracellular polyamines have a critical role in cell proliferation and death pathways, the polyamine metabolic pathway represents a potential target for intervention in cancers. A number of polyamine analogues have been identified that downregulate polyamine synthesis and enhance polyamine catabolism, thereby depleting intracellular polyamines. Treatment of human breast cancer cell lines in culture with these analogues has been shown to decrease cell proliferation and induce programmed cell death. Phase I studies with one analogue are now complete, setting the stage for phase II trials to determine efficacy, in addition to preclinical studies to examine combinations of polyamine analogues and conventional cytotoxics.

Original languageEnglish (US)
Pages (from-to)69-73
Number of pages5
JournalEndocrine-Related Cancer
Volume6
Issue number1
DOIs
StatePublished - Mar 1999

Fingerprint

Polyamines
Cell Death
Breast Neoplasms
Cell Proliferation
Metabolic Networks and Pathways
Down-Regulation
Cell Line
Neoplasms

ASJC Scopus subject areas

  • Endocrinology
  • Oncology
  • Cancer Research
  • Endocrinology, Diabetes and Metabolism

Cite this

Clinical aspects of cell death in breast cancer : The polyamine pathway as a new target for treatment. / Davidson, N. E.; Hahm, H. A.; McCloskey, D. E.; Woster, P. M.; Casero, Robert A.

In: Endocrine-Related Cancer, Vol. 6, No. 1, 03.1999, p. 69-73.

Research output: Contribution to journalArticle

Davidson, N. E. ; Hahm, H. A. ; McCloskey, D. E. ; Woster, P. M. ; Casero, Robert A. / Clinical aspects of cell death in breast cancer : The polyamine pathway as a new target for treatment. In: Endocrine-Related Cancer. 1999 ; Vol. 6, No. 1. pp. 69-73.
@article{d48a684153bc4aad825dac272f09db21,
title = "Clinical aspects of cell death in breast cancer: The polyamine pathway as a new target for treatment",
abstract = "Because intracellular polyamines have a critical role in cell proliferation and death pathways, the polyamine metabolic pathway represents a potential target for intervention in cancers. A number of polyamine analogues have been identified that downregulate polyamine synthesis and enhance polyamine catabolism, thereby depleting intracellular polyamines. Treatment of human breast cancer cell lines in culture with these analogues has been shown to decrease cell proliferation and induce programmed cell death. Phase I studies with one analogue are now complete, setting the stage for phase II trials to determine efficacy, in addition to preclinical studies to examine combinations of polyamine analogues and conventional cytotoxics.",
author = "Davidson, {N. E.} and Hahm, {H. A.} and McCloskey, {D. E.} and Woster, {P. M.} and Casero, {Robert A}",
year = "1999",
month = "3",
doi = "10.1677/erc.0.0060069",
language = "English (US)",
volume = "6",
pages = "69--73",
journal = "Endocrine-Related Cancer",
issn = "1351-0088",
publisher = "Society for Endocrinology",
number = "1",

}

TY - JOUR

T1 - Clinical aspects of cell death in breast cancer

T2 - The polyamine pathway as a new target for treatment

AU - Davidson, N. E.

AU - Hahm, H. A.

AU - McCloskey, D. E.

AU - Woster, P. M.

AU - Casero, Robert A

PY - 1999/3

Y1 - 1999/3

N2 - Because intracellular polyamines have a critical role in cell proliferation and death pathways, the polyamine metabolic pathway represents a potential target for intervention in cancers. A number of polyamine analogues have been identified that downregulate polyamine synthesis and enhance polyamine catabolism, thereby depleting intracellular polyamines. Treatment of human breast cancer cell lines in culture with these analogues has been shown to decrease cell proliferation and induce programmed cell death. Phase I studies with one analogue are now complete, setting the stage for phase II trials to determine efficacy, in addition to preclinical studies to examine combinations of polyamine analogues and conventional cytotoxics.

AB - Because intracellular polyamines have a critical role in cell proliferation and death pathways, the polyamine metabolic pathway represents a potential target for intervention in cancers. A number of polyamine analogues have been identified that downregulate polyamine synthesis and enhance polyamine catabolism, thereby depleting intracellular polyamines. Treatment of human breast cancer cell lines in culture with these analogues has been shown to decrease cell proliferation and induce programmed cell death. Phase I studies with one analogue are now complete, setting the stage for phase II trials to determine efficacy, in addition to preclinical studies to examine combinations of polyamine analogues and conventional cytotoxics.

UR - http://www.scopus.com/inward/record.url?scp=0032947019&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032947019&partnerID=8YFLogxK

U2 - 10.1677/erc.0.0060069

DO - 10.1677/erc.0.0060069

M3 - Article

C2 - 10732790

AN - SCOPUS:0032947019

VL - 6

SP - 69

EP - 73

JO - Endocrine-Related Cancer

JF - Endocrine-Related Cancer

SN - 1351-0088

IS - 1

ER -